Lumexa Imaging Holdings Prices IPO at $17.00-$20.00 Per Share (LMRI)

Lumexa Imaging Holdings (LMRI) expects to raise $462.50 million in an initial public offering (IPO) on Thursday, December 11th, IPO Scoop reports. The company will issue 25,000,000 shares at $17.00-$20.00 per share.

In the last 12 months, Lumexa Imaging Holdings generated $1.00 billion in revenue and had a net loss of $43.47 million. The company has a market cap of $1.75 billion.

Barclays, J.P.Morgan, Jefferies, Deutsche Bank Securities, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, Raymond James and PNC Capital Markets acted as the underwriters for the IPO.

Lumexa Imaging Holdings provided the following description of their company for its IPO: “(Incorporated in Delaware) We provide outpatient diagnostic imaging services through 184 outpatient centers in 13 states. We own some of the sites. Others are joint ventures. We offer a wide range of advanced and basic diagnostic imaging services, including MRIs, CTs, PET scans, X-rays, ultrasounds and mammograms. Lumexa Imaging was founded in 2018 by Charlotte Radiology and private equity firm Welsh, Carson, Anderson & Stowe. When we began, we operated 20 centers. Note: Net loss and revenue are for the 12 months that ended Sept. 30, 2025. (Note: Lumexa Imaging Holdings filed an S-1/A on Dec. 2, 2025, and disclosed the terms for its IPO: 25 million shares at a price range of $17.00 to $20.00 to raise $462.5 million, if priced at the $18.50 mid-point of its range. Background: Lumexa Imaging Holdings filed its S-1 on Nov. 17, 2025, without disclosing the terms for its IPO. Estimated initial proceeds are $100 million, a placeholder figure.) “.

Lumexa Imaging Holdings was founded in 2018 and has 5019 employees. The company is located at 4200 Six Forks Road Suite 1000 Raleigh, North Carolina 27609 and can be reached via phone at (919) 763-1100 or on the web at https://www.lumexaimaging.com/.